NCCN survey shows cancer drug shortages continue despite eff

The National Comprehensive Cancer Network- a non-profit alliance of leading cancer centers across the United States-;has released a follow-up survey on the ongoing chemotherapy shortages: 72% of the centers surveyed continue to experience a shortage of carboplatin and 59% are still seeing a shortage of cisplatin.

Related Keywords

United States , White House , District Of Columbia , Lily Ramsey , Robertw Carlson , Alyssa Schatz , National Cancer Institute , National Comprehensive Cancer Network , Practices Committee , Centers For Medicaid , Biologics Compendium , Practice Guidelines , Chief Executive Officer , Senior Director , Federal Government , Cancer , Chemotherapy , Cancer Treatment , Carboplatin , Cisplatin , Drugs , Education , Ncology , Research ,